The First Faculty of Medicine of Charles University is one of five medical faculties of Charles University, Prague, Czech Republic. Founded in 1348 at the same time as the university itself, it is the oldest medical faculty in Central Europe and the 11th oldest medical institution in the world.

During the past decade, Charles University, Internal Medicine Department, (PAH unit) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Charles University, Internal Medicine Department, (PAH unit)" are "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Charles University, Internal Medicine Department, (PAH unit)" in a lesser frequency.

Most popular intervention types in "Charles University, Internal Medicine Department, (PAH unit)" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "bosentan" (2 trials). Other intervention names were less common.

The vast majority of trials in "Charles University, Internal Medicine Department, (PAH unit)" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Charles University, Internal Medicine Department, (PAH unit)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Charles University, Internal Medicine Department, (PAH unit), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Charles University, Internal Medicine Department, (PAH unit), 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".